Contemporary HIV Treatment and Prevention 2022

Read expert faculty members’ summaries of key HIV studies from CROI 2022, including results from studies of prevention strategies, long-acting therapies, second-line therapies, comorbidities, and cure.

Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director Released: April 28, 2022

Read expert faculty members’ summaries of cutting-edge concepts in HIV care, including the latest for long-acting therapies and prevention.

Joseph J. Eron, Jr., MD
Program Director Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director Darcy Wooten, MD Released: September 23, 2022

Read expert faculty members’ summaries of key HIV studies from CROI 2022, including results from studies of prevention strategies, long-acting therapies, second-line therapies, comorbidities, and cure.

Joseph J. Eron, Jr., MD
Program Director Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director Daniel R. Kuritzkes, MD Released: May 2, 2022

Read expert faculty summaries on the latest data in first-line ART therapy in diverse patients to assist with individualized ART selection.

Joseph J. Eron, Jr., MD
Program Director Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director Princy N. Kumar, MD, FIDSA, MACP Released: April 1, 2022

Read expert faculty members’ summaries of barriers and solutions to PrEP uptake in key populations including, adolescents, Black and Hispanic/Latinx people, cisgender women, transgender women, and people who inject drugs.

Joseph J. Eron, Jr., MD
Program Director Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director Gregory Huhn, MD, MPHTM Released: May 4, 2022

Read expert faculty members’ summaries of state-of-the-art switch strategies in virologically suppressed patients, including switching ART in the setting of resistance, considerations for long acting injectables, and switching ART prior to or during pregnancy.

Joseph J. Eron, Jr., MD
Program Director Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director Paul E. Sax, MD Released: May 6, 2022

Read expert faculty members’ summaries of barriers and solutions to PrEP uptake in key populations including, adolescents, Black and Hispanic/Latinx people, cisgender women, transgender women, and people who inject drugs.

Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director Released: September 22, 2022

Read expert faculty members’ summaries of barriers and solutions to PrEP uptake in key populations including, adolescents, Black and Hispanic/Latinx people, cisgender women, transgender women, and people who inject drugs.

Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director Released: September 23, 2022

Read expert faculty members’ summaries of cutting-edge concepts in HIV care, including the latest for long-acting therapies and prevention.

Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director Released: May 31, 2022

Download slides to review expert insights into strategies for overcoming virologic failure in heavily treatment–experienced patients and selecting optimized switch regimens for virologically suppressed patients with underlying resistance and significant potential drug–drug interactions.

Joseph J. Eron, Jr., MD
Program Director Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director Eric S. Daar, MD Released: December 13, 2022

Read expert faculty members’ summaries of key HIV studies from AIDS 2022, including results from studies of prevention strategies, oral therapies, long-acting therapies, cure, COVID-19 in PWH, and Monkeypox.

Joseph J. Eron, Jr., MD
Program Director Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director David A. Wohl, MD Released: September 23, 2022

Read expert faculty members’ summaries of key HIV studies from AIDS 2022, including results from studies of prevention strategies, oral therapies, long-acting therapies, and COVID-19 in PWH.

Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director Released: September 23, 2022

Read expert nursing faculty members’ summaries of cutting-edge concepts in HIV care, including the latest for long-acting therapies and prevention.

Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director Released: November 22, 2022

Download slides to review expert pharmacist insights into strategies for overcoming virologic failure in heavily treatment–experienced patients and selecting optimized switch regimens for virologically suppressed patients with underlying resistance and significant potential drug–drug interactions.

Joseph J. Eron, Jr., MD
Program Director Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director Released: January 10, 2023

Download slides to review expert nurse insights into strategies for overcoming virologic failure in heavily treatment–experienced patients and selecting optimized switch regimens for virologically suppressed patients with underlying resistance and significant potential drug–drug interactions.

Joseph J. Eron, Jr., MD
Program Director Jeffrey Kwong, DNP, MPH, AGPCNP-BC, ACRN, FAANP, FAAN, AAHIVS
Program Director Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director Released: January 11, 2023